-
1 day ago | 
afr.com | Michael Smith |Michaël Smith
May 14, 2025 – 5.00am or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? Global insurance giant Bupa wants to build a network of 130 medical centres in Australia over the next three years, potentially adding to tensions with struggling private hospital operators over the growing role of insurers in patient care.
-
3 days ago | 
afr.com | Michael Smith |Michaël Smith
May 12, 2025 – 12.15pm or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? Healthscope, Australia’s second-largest hospital operator, will transfer board control to lenders under a proposal it says will enable the troubled group to remain solvent as it seeks a new owner for its network of 38 hospitals.
-
6 days ago | 
afr.com | Michael Smith |Michaël Smith
May 9, 2025 – 10.59am or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? When Chris Blake suggests we have hospital food for lunch, I am wary. The view from the 15th floor of St Vincent’s Private Hospital in the inner-Sydney suburb of Darlinghurst is stunning, and we have a spacious dining room to ourselves. Loading...
-
1 week ago | 
afr.com | Michael Smith |Michaël Smith
May 7, 2025 – 5.03pm or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? Ramsay Health Care, the country’s biggest hospital operator, has not ruled out buying Healthscope hospitals if high-quality assets come onto the market.
-
1 week ago | 
afr.com | Michael Smith |Michaël Smith |Carrie LaFrenz |Amelia McGuire
Michael Smith, Carrie LaFrenz and Amelia McGuireMay 6, 2025 – 7.25pm or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? Macquarie Group chief executive Shemara Wikramanayake says Australia will pay the price for complacency if Anthony Albanese’s second-term government and business do not take decisive action to safeguard the country from rising global political turmoil.
-
1 week ago | 
afr.com | Michael Smith |Michaël Smith
May 6, 2025 – 4.54pm or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? Sigma Healthcare, the retail and pharmacy giant that merged with Chemist Warehouse, expects to continue opening up to 30 new stores in Australia each year as demand for weight-loss medicines and other cheap drugs drives double-digit sales growth.
-
1 week ago | 
afr.com | Michael Smith |Michaël Smith |Amelia McGuire
May 5, 2025 – 8.00pm or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? As Donald Trump slashes funding to US science, researchers and tech industry chiefs are holding out hope that Labor’s election victory will have the opposite result in Australia.
-
1 week ago | 
afr.com | Michael Smith |Michaël Smith |Tom Rabe |Carrie LaFrenz
Michael Smith, Tom Rabe and Carrie LaFrenzMay 4, 2025 – 4.49pm or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? Australia’s business chiefs are calling on Labor to prioritise a productivity agenda which unlocks long-term economic growth and use its strong mandate to make tough decisions on workplace reform, overhaul the tax system and remove regulatory barriers.
-
1 week ago | 
afr.com | Michael Smith |Michaël Smith
May 2, 2025 – 5.00am or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? Not long after we sit down for lunch, Tom Oxley asks me if I have watched the Netflix sci-fi series Black Mirror. I have, in fact, just finished bingeing the latest series, which centres on dystopian tales of transferable human consciousness and brain implants. Loading...
-
2 weeks ago | 
afr.com | Michael Smith |Michaël Smith
May 1, 2025 – 8.00pm or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? ASX-listed Dimerix has landed one of the biggest licensing deals by an Australian biotechnology company after US pharmaceutical group Amicus Therapeutics agreed to $940 million in payments for future sales of its kidney disease drug.
